🇺🇸 PCRX — Pacira BioSciences, Inc.

Salud Mantener
← Volver

Precio actual

36,40 USD

Máx. histórico

119,27

4268 días

Caída desde máximo

-69,48%

Rango 52 semanas

18,80 – 36,67

Variación hoy

+0,03%

Cierre anterior

36,39

Rango de hoy

36,38 – 36,41

Volumen hoy

810.925

Peor caída histórica

-90,19%

25/02/2015 → 09/08/2024

Aún sin recuperar

Volatilidad anualizada ⓘ

50,37%

Información
Nombre completo
Pacira BioSciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
825
PER ⓘ
104,00 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
33,57 USD (puede no estar actualizado)
Primera cotización
03/02/2011
Precio actualizado
hace 1 día
Sobre la empresa

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Brisbane, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
29/02/2012 10,94 11,00 10,54 10,70 -1,92% 4,20% 99.800
28/02/2012 11,00 11,33 10,82 10,91 -0,18% 4,64% 61.500
27/02/2012 10,71 11,30 10,60 10,93 +2,15% 6,54% 120.200
24/02/2012 10,42 10,73 10,40 10,70 +1,42% 3,17% 40.200
23/02/2012 10,40 10,59 10,27 10,55 +1,93% 3,08% 69.900
22/02/2012 10,06 10,48 9,89 10,35 +2,48% 5,86% 56.500
21/02/2012 10,65 10,72 10,05 10,10 -5,52% 6,29% 70.700
17/02/2012 10,24 10,73 10,19 10,69 +4,70% 5,27% 53.700
16/02/2012 10,50 10,56 10,05 10,21 -2,95% 4,86% 70.900
15/02/2012 10,84 10,97 10,41 10,52 -3,04% 5,17% 114.200
14/02/2012 10,44 10,94 10,34 10,85 +3,14% 5,75% 113.000
13/02/2012 10,40 10,57 10,22 10,52 +1,94% 3,37% 123.400
10/02/2012 10,30 10,33 10,13 10,32 -0,77% 1,94% 27.200
09/02/2012 10,49 10,60 10,16 10,40 -0,86% 4,19% 59.100
08/02/2012 10,00 10,64 9,96 10,49 +4,59% 6,80% 129.200
07/02/2012 10,42 10,42 9,95 10,03 -3,65% 4,51% 80.800
06/02/2012 10,63 10,88 10,27 10,41 -2,89% 5,74% 83.700
03/02/2012 10,90 11,18 10,62 10,72 -1,56% 5,14% 105.800
02/02/2012 10,98 11,01 10,70 10,89 -1,00% 2,82% 95.200
01/02/2012 10,79 11,09 10,79 11,00 +1,85% 2,78% 212.100
31/01/2012 10,86 11,21 10,48 10,80 -0,28% 6,72% 208.100
30/01/2012 10,02 10,86 9,99 10,83 +7,87% 8,68% 337.300
27/01/2012 9,52 10,17 9,40 10,04 +10,33% 8,09% 420.000
26/01/2012 9,04 9,30 8,90 9,10 +0,44% 4,42% 87.000
25/01/2012 8,74 9,17 8,68 9,06 +4,14% 5,61% 39.500
24/01/2012 8,81 8,81 8,61 8,70 -1,69% 2,27% 64.300
23/01/2012 8,85 8,94 8,57 8,85 +0,00% 4,18% 42.800
20/01/2012 8,45 8,85 8,45 8,85 +4,24% 4,73% 84.300
19/01/2012 8,77 8,84 8,43 8,49 -2,86% 4,68% 40.500
18/01/2012 8,20 8,92 8,20 8,74 +6,59% 8,78% 101.900